205873-57-0

Basic information

• Product Name: (3-Bromo-2-methoxyphenyl)methanol
• Synonyms: (3-Bromo-2-methoxyphenyl)methanol;3-Bromo-2-methoxybenzenemethanol;(3-BROMO-2-METHOXYPHENYL)METHANOL(WX900107)
• CAS NO: 205873-57-0
• Molecular Formula: C₈H₉BrO₂
• Molecular Weight: 217.05986
• Mol File: 205873-57-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (3-Bromo-2-methoxyphenyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-Bromo-2-methoxyphenyl)methanol(205873-57-0)
• EPA Substance Registry System: (3-Bromo-2-methoxyphenyl)methanol(205873-57-0)

Safety Data

• Hazardous Substances Data: 205873-57-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(3-Bromo-2-methoxyphenyl)methanol is used as a key reactant for the synthesis of antiprotozoal agents, which are essential in the development of treatments targeting parasitic infections. Its specific functional groups facilitate the creation of bioactive molecules that can effectively combat protozoan pathogens.
Used in Organic Synthesis:
In the field of organic synthesis, (3-Bromo-2-methoxyphenyl)methanol serves as an intermediate for the preparation of a variety of organic compounds. Its bromo and methoxy substituents can be further modified or used as starting points for the synthesis of complex organic molecules, including pharmaceuticals, agrochemicals, and specialty chemicals. This makes it a valuable building block in the development of new and innovative products.

Upstream product

• 260806-90-4 methyl 3-bromo-2-methoxybenzoate 
• 101084-39-3 2-methoxy-3-bromobenzoic acid 

Downstream Products

• 1044256-82-7 1-azidomethyl-3-bromo-2-methoxy-benzene 

Relevant articles and documents

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator. The compounds and methods are also use

ARYL FLUOROETHYL UREAS ACTING AS ALPHA 2 ADRENERGIC AGENTS

The invention provides well-defined aryl fluoroethyl ureas that are useful as selective alpha2 adrenergic agonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of alpha2 adrenergic receptors.